Spotify Technology (SPOT) just kicked off its 2025 Wrapped campaign, turning year end listening habits into a global event that now includes real time social features like Wrapped Party and offline pop up experiences.
See our latest analysis…
Category: 6. Business
-
Is American Bitcoin Attractively Priced After a 65% Drop Amid Crypto Volatility?
-
Wondering if American Bitcoin at around $2.23 is a bargain or a value trap? You are not alone. This article is here to unpack what the market is really pricing in.
-
Despite all the hype around crypto infrastructure, the stock has been…
Continue Reading
-
-
Ben & Jerry’s founders told to ‘hand over to a new generation’ by Magnum boss
Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Ben & Jerry’s co-founder Ben Cohen has clashed with the boss of Unilever’s ice cream spin-off after being told to…
Continue Reading
-
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops,…
Continue Reading
-
Epcoritamab Plus R-mini-CHOP May Aid in Treatment of Elderly Patients with First-Line DLBCL
Treatment with fixed-duration epcoritamab-bysp (Epkinly) plus dose-attenuated rituximab (Rituxan) plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-mini-CHOP) appeared to be well tolerated and elicited responses in elderly…
Continue Reading
-
Is STAAR Surgical Attractive After Multi Year Share Price Slide And DCF Upside?
-
Wondering whether STAAR Surgical at around $25 a share is a bargain or a value trap? Let us unpack what the market is really pricing in and what the fundamentals say.
-
The stock is roughly flat over the last year at about 0.3% while still up…
Continue Reading
-
-
Berkshire Hathaway (BRK.B) Valuation Check After Steady Share Price Gains
Berkshire Hathaway (BRK.B) quietly keeps doing what it does best, compounding value in the background while the market chases headlines. With the stock grinding higher this year, it is worth unpacking what is driving that steady climb.
See…
Continue Reading
-
Odronextamab Plus CHOP Produces Deep, Potentially Durable Responses in Previously Untreated DLBCL
The CD20 × CD3-directed bispecific antibody odronextamab produced high, potentially durable complete responses (CR) and had a generally manageable safety profile when administered in combination with standard CHOP chemotherapy to patients with…
Continue Reading
-
Rusfertide Continues to Show Strong Results for Polycythemia Vera
Treatment with the hepcidin mimetic rusfertide continued to demonstrate sustained hematocrit control below 45% and high rates of phlebotomy ineligibility through week 52 for patients with polycythemia vera (PV), according to updated findings…
Continue Reading
